X
Get new exclusive access to healthcare business reports & breaking news
Nqaba Matshazi Nqaba has been working as an investigative journalist for the last 10 years. He has written for various media outlets across the world.
Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing personalized cancer immunotherapies, announced September 3rd it has closed a £100 ...
Cancer drugs account for more than a quarter of new U.S. Food and Drug Administration (FDA) approvals, a ...
